Transcription of Phenazepam - WHO
{{id}} {{{paragraph}}}
Phenazepam Pre-Review Report Agenda item Expert Committee on Drug Dependence Thirty-seventh Meeting Geneva, 16-20 November 2015 37th ECDD (2015) Agenda item Phenazepam Page 2 of 32 37th ECDD (2015) Agenda item Phenazepam Page 3 of 32 Contents Acknowledgements .. 5 Summary .. 6 1. Substance identification .. 7 A. International Nonproprietary Name (INN).. 7 B. Chemical Abstract Service (CAS) Registry Number .. 7 C. Other Names .. 7 D. Trade Names .. 7 E. Street Names .. 7 F. Physical properties .. 7 G. WHO Review History .. 7 2. Chemistry .. 7 A. Chemical Name .. 7 B. Chemical Structure .. 7 C. Stereoisomers .. 8 D. Synthesis .. 8 E. Chemical description .. 8 F. Chemical 8 G. Chemical identification .. 8 3. Ease of convertibility into controlled substances .. 9 4. General pharmacology .. 9 A. 9 B. Routes of administration and 12 C. Pharmacokinetics .. 12 5.
37th ECDD (2015) Agenda item 5.8 Phenazepam Page 5 of 32 Acknowledgements This report has been drafted under the responsibility of the WHO Secretariat, Essential Medicines and Health Products, Policy Access and Use team.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Two chiral centres diastereoisomers, STEREOISOMERS, Sapling Learning, Lecture 5 - Stereochemistry in Transition Metal Complexes, 18 MEDICINAL CHEMISTRY 18.1 Introduction, CHEMICAL SCIENCES, Of Psychotropic Substances under International Control, Psychotropic substances under international control, Toxicology CPT Code Changes for, Quest Diagnostics, TRAMADOL Pre-Review Report